Mr. Damien McCallion:

There are a small number left, which is partly related to issues like outbreaks in certain settings and our ability to go back. We will be continuing through April. Some of those could probably take a little bit of time to wrap up. Essentially, all dose 1 and the majority of dose 2 are done, with a percentage left to be done going back through outbreaks. That work will continue but it is a timing issue.